Weisgraber KH and Mahley RW. (1996) Human apolipoprotein E: The Alzheimer’s disease connection. FASEB J. 10: 1485–1494.
Dong L-M and Weisgraber KH. (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to determine the preference for very low density lipoproteins. J. Biol. Chem. 271: 19053–19057.
Raffai RL, Dong LM, Tow B, Farese RV, Weisgraber KH. (2000) Generation of a mouse model for human apolipoprotein (apo) E4 using gene targeting. Circulation 102: II-150 (abstr.).
Raffai RL, Weisgraber KH. (2002) Hypomorphic apolipoprotein E mice. A new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J. Biol. Chem. 277: 11064–11068.
Morrow JA, Segall ML, Lund-Katz S, Phillips MC, Knapp M, Rupp B, Weisgraber KH. (2000) Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry 39: 11657–11666.
Libeu CP, Lund-Katz S, Phillips MC, Wehrli S, Hern iz MJ, Capila I, Linhardt RJ, Raffai RL, Newhouse YM, Zhou F, Weisgraber KH. (2001) New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. J. Biol. Chem. 276: 39138–39144.
Zhong N, Weisgraber KH. (2009) Understanding the association of apolipoprotein E4 with Alzheimer disease: Clues from its structure. J. Biol. Chem. 284: 6027–6031.
